SEC Form 3 · accession 0000899243-16-025701
OCULAR THERAPEUTIX, INC · OCUL
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jonathan H. Talamo
Officer — Chief Medical Officer
Period of report
Jul 25, 2016
Accepted (ET)
Jul 26, 2016 · 4:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001393434
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| No securities are benefically owned | holding | — | — | — | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $5.93 | holding | — | — | — | — | Feb 2, 2026 | Common Stock | 72,000 | — | D |
Explanation of responses
- F1This option was granted on February 2, 2016 and vests over four years, with 25% of the shares underlying the option vesting on January 8, 2017 and 2.0833% of the shares vesting monthly thereafter.
Remarks
Exhibit List Exhibit 24 - Power of Attorney